B3490 - Neurodevelopmental Disorders and Cardiometabolic Risk in ALSPAC Cohort - 31/03/2020

B number: 
B3490
Principal applicant name: 
Daniel Kerr | University of Glasgow (United Kingdom)
Co-applicants: 
Professor Helen Minnis, Prof Rebecca Reynolds, Dr Abigail Fraser
Title of project: 
Neurodevelopmental Disorders and Cardiometabolic Risk in ALSPAC Cohort
Proposal summary: 

Neurodevelopmental disorders (such as autism, ADHD, learning disability, and Tic Disorders) are lifelong conditions which begin in childhood and can have significant impacts on physical and mental health, and social well-being across the lifespan.
People with neurodevelopmental disorders have reduced life expectancy than people without such conditions (neurotypicals). Cardiovascular disease (such as heart attacks and strokes) is a significant contributor to this reduced life-expectancy. It is unclear why people with neurodevelopmental disorders are at increased risk of premature cardiovascular disease. Possible explanations include higher levels of cardiovascular risk factors (such as smoking, obesity, and physical inactivity) in people with neurodevelopmental disorders; difficulties in people with neurodevelopmental disorders accessing healthcare; and potentially shared biological mechanisms which contribute to causing both neurodevelopmental disorders and cardiovascular disease (such as over or under active immune systems).

This project aims to improve understanding of the association of neurodevelopmental disorders and cardiovascular disease. We aim to compare rates of cardiovascular risk factors (blood pressure, body mass index, cholesterol, glucose, insulin, and CRP- a measure of the immune system) and very early cardiovascular disease (as measured by the stiffness of arteries) between young adults (at aged 17 and 24) with neurodevelopmental disorders and without. We predict that young adults with neurodevleopmental disorders will have higher rates of both cardiovascular risk factors and very early cardiovascular disease when compared with neurotypical young adults. If this were to the case it would support a view that people with neurodevelopmental disorders are inherantly at increased risk of cardiovascular disease independent of their access to healthcare and would support policies for screening and early intervention in this group.

Impact of research: 
We hypothesis that young adults with neurodevelopmental conditions will have higher burdens of cardiovascular risk factors and subclinical cardiovascular disease than neurotypical young adults, we further hypothesis that there will be a dose response relationship between number of neurodevelopmental disorder and burden of cardiovascular risk factors and subclinical cardiovascular disease. If this is the case it will support that people with neurodevelopmental disorders are inherently at increased risk of cardiosvuarl disease independent of their access to healthcare which would support policies of early screening and preventative interventions in this group. Furthermore it would support further research to explore mechanisms of this association. If our hypothesis is not supported it would suggest that the differences in outcome are occurring later in the lifespan and would support further research in different samples (or in ALSPAC in the future) to elucidate these mechanisms.
Date proposal received: 
Friday, 27 March, 2020
Date proposal approved: 
Tuesday, 31 March, 2020
Keywords: 
Mental health - Psychology, Psychiatry, Cognition, Developmental disorders - autism, Hypertension, Mental health, Obesity, Statistical methods, Blood pressure, BMI, Cardiovascular, Statistical methods